Acesion Pharma
PrivateLast Round
Series B
Sep 26, 2023
Total Funding Raised
$65.89M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Acesion Pharma operates in Healthcare & Life Sciences and is based in Copenhagen. Its latest recorded funding round was a Series B round in September 2023.
Acesion Pharma is a biotechnology company that develops selective small-molecule inhibitors targeting SK channels to treat atrial fibrillation.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Acesion Pharma Comparables
Compare Acesion Pharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Thryv Therapeutics | 81% | |
| XYRA LLC | 79% | |
| Revadix | 78% |
For institutional investors. Book with your work email.
Acesion Pharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Sep 26, 2023 | ||||
| Grant | Mar 12, 2019 | ||||
| Series A | Oct 31, 2016 | ||||
| Seed | Dec 17, 2014 | ||||
| Seed | Dec 15, 2011 | ||||
Seed | Dec 1, 2010 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Acesion Pharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovation Fund Denmark | Grant |
| RM Global Partners | Series B |
| Novo Holdings | Seed, Series B, Series A |
| Canaan Partners | Series B |
| SEED Capital | Series A |
| Seed Capital | Seed |
| FC Capital | Series B |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors grew 121% MoM, from 294 to 650.
- Jan 6, 2026
Developing novel mechanism for rhythm control of atrial fibrillation.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- is_developingOct 2, 2026
Acesion Pharma ApS aims to develop first-in-class SK channel inhibitors as a more efficacious, safe and tolerable treatment for atrial fibrillation.
- is_developingOct 2, 2026
Acesion Pharma ApS is developing novel treatments for atrial fibrillation in Denmark, including first-in-class SK channel inhibitors intended to offer more efficacious, safe, and tolerable treatment.
For institutional investors. Book with your work email.
Acesion Pharma Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Acesion Pharma's valuation, stock price, and market status.
Is Acesion Pharma a public or private company?
Acesion Pharma is a private company.
What is the current stock price of Acesion Pharma?
Acesion Pharma is a private company, so its shares have no public market price. Caplight tracks Acesion Pharma's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Acesion Pharma worth (valuation)?
Valuation information for Acesion Pharma is not publicly available.
Can I buy Acesion Pharma stock?
Acesion Pharma shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Acesion Pharma's last funding round?
Acesion Pharma's most recent funding round was Series B on September 26, 2023.
Who are the main investors in Acesion Pharma?
Key investors in Acesion Pharma include Novo Holdings, Canaan Partners, Alpha Wave Global, Broadview Ventures.
Will Acesion Pharma IPO soon?
No public IPO plans have been announced for Acesion Pharma.
How can I track Acesion Pharma secondary market activity?
Caplight tracks bids, offers, and trades in Acesion Pharma's shares on secondary markets.